The DOI matches its Crossref record.
Acquired Immunodeficiency Syndrome in African Patients
Abstract
Between May 1979 and April 1983, 18 previously healthy African patients were hospitalized in Belgium with opportunistic infections (cryptococcosis, Pneumocystis carinii pneumonia, central-nervous-system toxoplasmosis, progressive cutaneous herpes simplex virus infection, disseminated cytomegalovirus infection, candidiasis, or cryptosporidiosis) or Kaposi's sarcoma, or with both. Ten of them died. During the same period five other patients were hospitalized with an illness consistent with a prodrome of the acquired immunodeficiency syndrome (chronic lymphadenopathy, fever, weight loss, and diarrhea). All patients tested had a marked decrease in helper T cells; an inversion of the normal ratio of helper to suppressor T cells, and a decreased or absent blastogenic response of lymphocytes to mitogens. Twenty patients had anergy. There was no evidence of an underlying immunosuppressive disease and no history of blood-product transfusion, homosexuality, or intravenous-drug abuse. This syndrome in patients originating in Central Africa is similar to the acquired immunodeficiency syndrome reported in American patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MRSA accounts for approximately 5% of culturepositive infections among critically ill patients (133), and may be decreasing according to some reports (134, 135).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [134]
Citations
Cites
Still being checked.
Research works printed but not linked: 25
- 10.1001/jama.1983.03330410061029 · DOI
- 10.1016/S0140-6736(83)91808-1 · DOI
- Mascart-Lemone, 1982, Clin Exp Immunol, 48, 148
- 10.1016/S0140-6736(74)92982-1 · DOI
- Lamy, 1977, J Clin Microbiol, 6, 66, 10.1128/jcm.6.1.66-71.1977 · DOI
- 10.1001/jama.198.6.624 · DOI
- 1982, N Engl J Med, 306, 248
- Wyler, 1976, Clin Exp Immunol, 23, 471
- Askonas, 1979, Immunology, 36, 313
- 10.1056/NEJM198202183060702 · DOI
- Wilkins, 1977, Ann Trop Med Parasitol, 71, 59, 10.1080/00034983.1977.11687162 · DOI
- 10.1016/S0140-6736(71)90267-4 · DOI
- 10.1126/science.6601823 · DOI
- 10.1126/science.6342136 · DOI
- 10.1126/science.6601822 · DOI
- 10.1016/S0140-6736(81)91352-0 · DOI
- 10.1016/S0140-6736(83)92117-7 · DOI
- 10.1016/S0140-6736(83)91985-2 · DOI
- Barin, 1981, Prog Med Virol, 27, 148
- Oettle, 1962, Acta Un Int Cancer, 18, 330
- 10.1002/ijc.2910080116 · DOI
- 10.1016/S0140-6736(73)91450-5 · DOI
- Renoirte, 1967, Bull Acad Roy Med Belg, 7, 465
- Lamey, 1982, Med Trop, 42, 507
- Thijs, 1963, Trop Geogr Med, 15, 158
Cited by
Sorted by citations
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Metadata
- Authors
- Clumeck, N., Sonnet, J., Taelman, H., Mascart-Lemone, F., De Bruyere, M., Vandeperre, P., Dasnoy, J., Marcelis, L., Lamy, M., Jonas, C., Eyckmans, L., Noel, H., Vanhaeverbeek, M., & Butzler, J.-P.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1984-02-23
- Volume
- 310
- Issue
- 8
- Pages
- 492-497
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2008190687
- Cited by
- 301
- References
- 0
- Citations by year
- 2023: 2 · 2021: 4 · 2020: 2 · 2016: 3 · 2015: 3 · 2014: 6 · 2013: 2 · 2012: 5
- FWCI
- 10.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- AIDS, African patients, opportunistic infections, cryptococcosis, Pneumocystis carinii pneumonia, toxoplasmosis, herpes simplex virus, cytomegalovirus infection, candidiasis, cryptosporidiosis, Kaposi's sarcoma, lymphocyte anergy, lymphocyte proliferation, Central Africa
- MeSH terms
- Acquired Immunodeficiency Syndrome, Adult, Africa, Central, Belgium, Female, T-Lymphocytes, Helper-Inducer, Humans, Infections, Lymphocyte Activation, Male, Middle Aged, Sarcoma, Kaposi, Democratic Republic of the Congo, T-Lymphocytes, Regulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review